Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2008
04/02/2008CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
04/02/2008CN101155788A Crystal of 4(3h)-quinazolinone derivative
04/02/2008CN101155787A (3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines
04/02/2008CN101155781A Pyridine-3-carboxamide derivatives as cb1 inverse agonists
04/02/2008CN101155593A Use of iron(iii) complex compounds
04/02/2008CN101155587A Modulators of muscarinic receptors
04/02/2008CN101155580A Propofol-containing fat emulsion
04/02/2008CN101153043A Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them
04/02/2008CN101153042A Thienopyrimidine compound and use of the same
04/02/2008CN101152576A Medicament for preventing and controlling alzheimer's disease
04/02/2008CN101152565A Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
04/02/2008CN101152559A Pharmaceutical composition having function of protecting and treating nerve damnification
04/02/2008CN101152537A Traditional Chinese medicine for treating hysteria asphyxia of female
04/02/2008CN101152531A Heart-nourishing brain-nourishing traditional Chinese medicine preparation for treating amnesia
04/02/2008CN101152517A Biological agent for releasing and smoothing emotional stress, and method for preparing the same
04/02/2008CN101152514A Traditional Chinese medicine for treating customary children's urorrhea
04/02/2008CN101152513A Traditional Chinese medicine for treating children's urorrhea from mental load
04/02/2008CN101152461A Gastrodia tuber wine for treating wandering arthritis, hemiplegia of hands and feets of women
04/02/2008CN101152458A Traditional Chinese medicine preparation for treating cerebral apoplexy sequela
04/02/2008CN101152455A Medicine for external application for treating hemiparalysis
04/02/2008CN101152441A Traditional Chinese medicine health care food
04/02/2008CN101152431A Traditional Chinese medicine for treating hysteria
04/02/2008CN101152383A Traditional Chinese medicine for treating hysteria palsy
04/02/2008CN101152373A Massage agent for treating malaise of head and method for preparing the same
04/02/2008CN101152372A Traditional Chinese medicine for treating children's urorrhea of liver channel damp-heat
04/02/2008CN101152359A Health care medicinal liquor and preparation method thereof
04/02/2008CN101152349A Multifunctional health care medical pillow and its preparing process
04/02/2008CN101152330A Traditional Chinese medicine for treating hysterical attack
04/02/2008CN101152318A Traditional Chinese medicine with cooperativeness therapy
04/02/2008CN101152296A Aromatic essential oil capable of calming oneself and accelerating sleep, and uses of the same
04/02/2008CN101152288A Traditional Chinese medicine with anti-inebriation function
04/02/2008CN101152281A Compound rhodamine oil soft capsule and method for preparing the same
04/02/2008CN101152280A Traditional Chinese medicine for treating children's night cry in suspense
04/02/2008CN101152266A Traditional Chinese medicine preparations and use of the same
04/02/2008CN101152229A Notoginseng total saponin orally disintegrating tablets and method for preparing the same
04/02/2008CN101152221A Traditional Chinese medicine for treating cerebrovaseular disease
04/02/2008CN101152208A Application of brown seaweed polyoses sulfate in preparing medicament for treating senile dementia
04/02/2008CN101152207A Application of laver polyoses in preparing medicament for preventing and treating neurous system disease
04/02/2008CN101152205A Inosine injection and method of preparing the same
04/02/2008CN101152201A Application of isoquercitrin in preparing medicament for preventing and/or treating melancholia
04/02/2008CN101152196A Application of notoginsen triterpenes and its monomer in preparing medicament for treating melancholia
04/02/2008CN101152194A Use of panaxoside Rg in against cerebral ischemia and relative diseases
04/02/2008CN101152178A Sophoridine nano liposome medicament and preparation of the same
04/02/2008CN101152175A Oxiracetam preparation and method of preparing the same
04/02/2008CN101152173A Use of liquiritigenin in preparing medicament for treating neurodegenerative diseases
04/02/2008CN101152153A Pharmaceutical composition containing rasagiline
04/02/2008CN101152143A Solid pharmaceutical composition containing agomelatine
04/02/2008CN101151975A Pastry with help for sleep and production technique of the same
04/02/2008CN100378119C Gen-seng saponin Rg2 preparation method, its pharmaceutical composition and uses in pharmacy
04/02/2008CN100378109C Tetracyclic 3-substituted indoles having serotonin receptor affinity
04/02/2008CN100378108C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
04/02/2008CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives
04/02/2008CN100378095C Substituted indoles as alpha-1 agonists
04/02/2008CN100378090C Substituted dioxopentacyclic derivative and its use in preparing neuro regulator
04/02/2008CN100378083C Carboxylic acid compounds and drugs containing the compounds as the active ingredient
04/02/2008CN100378075C Aniline derivative using as phosphodiesterase 4 inhibitor
04/02/2008CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
04/02/2008CN100378064C Active metabolic product of phencynonate and its medicinal use
04/02/2008CN100377734C Extract of plant dendrobii caulis and preparing process and use thereof
04/02/2008CN100377720C Chinese medicine herb prescription for treating neuralgia and capital necrosis
04/02/2008CN100377718C Alcohol-neutralizing agent composition containing hyaluronic acid
04/02/2008CN100377717C Glycosaminoglycans for treating emotional dysfunctions
04/02/2008CN100377714C Application of steroidal sapogenins and their derivatives in medicine preparation
04/02/2008CN100377711C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
04/02/2008CN100377707C Application of cucoline in preparation of medicine for treating macular degeneration, pigmentary degeneration of retina and diabetes retinosis
04/02/2008CN100377658C Substituted tea for clearing heat, relieving summer heat, removing alcohol, diuresis and relieving struct and its production method
04/01/2008US7351874 Transgenic animals for use in the treatment of nervous system disorders
04/01/2008US7351844 Adjust diffusion of oxygen; respiratory system disorders; cardiovascular disorders
04/01/2008US7351839 Process for the preparation of 1,2,3,4,8,9,10, 10a-octahydro-7bH-cyclopenta[b][1,4]diazepino-[6,7,1-hi]indole derivatives
04/01/2008US7351826 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
04/01/2008US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide
04/01/2008US7351737 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity
04/01/2008US7351736 Therapeutic compositions (II)
04/01/2008US7351734 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
04/01/2008US7351730 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
04/01/2008US7351710 Solid N-Methyl-N-[3-[3-[2-thienylcarbonyl]pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]acetamide; X-ray powder diffraction pattern lacks discernible or sharp peaks
04/01/2008US7351707 Spiroazacyclic compounds as monoamine receptor modulators
04/01/2008US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient
04/01/2008US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis
04/01/2008US7351702 Caspase inhibitors and uses thereof
04/01/2008US7351695 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability
04/01/2008US7351686 Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides
04/01/2008US7351401 Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition
04/01/2008US7350331 Method for producing metabolites from plants cultivated in soil-less medium
04/01/2008CA2446574C Liquid pharmaceutical composition
04/01/2008CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
04/01/2008CA2414320C Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
04/01/2008CA2341240C Autoantibody inhibitors
04/01/2008CA2339004C Antioxidant composition and method of treating diseases using same
04/01/2008CA2303817C 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) and its use as medicament for treating excess of glucocorticoids
04/01/2008CA2298974C Thiazolobenzoheterocycles, preparation and medicines containing same
04/01/2008CA2175992C In situ modification and manipulation of stem cells of the central nervous system
03/2008
03/27/2008WO2008036653A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
03/27/2008WO2008036642A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
03/27/2008WO2008036579A1 Thiazole pyrazolopyrimidines as crf1 receptor antagonists
03/27/2008WO2008036541A1 Thiophene pyrazolopyrimidine compounds
03/27/2008WO2008036410A2 Methods and compositions for treating amyotrophic lateral sclerosis (als)
03/27/2008WO2008036282A1 Upregulating activity or expression of bdnf to mitigate cognitive impairment in asymptomatic huntington's subjects
03/27/2008WO2008036022A1 Tetrahydro-lh-pyrido[3,4-b] indole derivatives as cb1 receptor ligands
03/27/2008WO2008036021A1 Tetrahydro-lh-pyrido [3,4 -b] indole derivatives as cbl receptor ligands